Skip to main
BWAY
BWAY logo

Brainsway (BWAY) Stock Forecast & Price Target

Brainsway (BWAY) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

BrainsWay Ltd is experiencing a favorable advancement in its business operations, evidenced by a significant increase of over 50% in the equipment utilization rate since the establishment of its investment strategy. The company has also secured additional strategic investments, which are poised to accelerate revenue growth. Furthermore, the positive outcome from an initial equity financing transaction is seen as a beneficial template for future financial endeavors.

Bears say

The financial outlook for BrainsWay Ltd is negatively impacted by several significant risks, including the slower-than-anticipated adoption of its Deep TMS systems, which hinders revenue growth. Additionally, the company faces challenges in expanding reimbursement and market access that could limit its potential customer base and financial performance. Finally, there is concern over the ability to advance in additional treatment indications and the risk of long-term dilution, which may further weaken investor confidence and stock value.

Brainsway (BWAY) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Brainsway and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Brainsway (BWAY) Forecast

Analysts have given Brainsway (BWAY) a Buy based on their latest research and market trends.

According to 2 analysts, Brainsway (BWAY) has a Buy consensus rating as of Oct 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $18, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $18, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Brainsway (BWAY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.